<DOC>
	<DOCNO>NCT02562703</DOCNO>
	<brief_summary>This phase II , randomize , sham control , clinical trial . This clinical trial primary objective evaluate change depressive symptom transcutaneous Vagus Nerve Stimulation ( tVNS ) treatment protocol patient moderate / severe depressive episode .</brief_summary>
	<brief_title>tVNS Depression</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<criteria>1. patient 18 69 year 2. patient diagnosis depression accord SCID 3. score great equal 18 Hamilton Rating Scale 17item version ( equivalent moderate severe depressive episode ) 4. agreement participate study recommend IC . 1. patient psychiatric indication hospitalization 2. patient psychiatric comorbidity 3. patient diagnosis personality disorder 4. presence severe neurological medical disease neoplasms activity , neurodegenerative disease chronic disease uncompensated .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>